Fischer A (2001) Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet 357:1863–869
Casanova J-L, Abel L (2004) The human model: a genetic dissection of immunity to infection in natural conditions. Nat Rev Immunol 4:55–6
Billiau A, Heremans H, Matthys P (2003) The use of cytokine knockouts in animal models of autoimmune disease. In: Fantuzzi G (ed) Cytokine knockouts, 2nd edn. Humana, Totowa, NJ, pp 33–5
Bathon JM, Martin RW, Fleischman RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586-1593
Lipsky PE, van der Heijde DM, St. Clair EW et al (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N Engl J Med 343:1594–602
Doan T, Massarotti E (2005) Rheumatoid arthritis: an overview of new and emerging therapies. J Clin Pharmacol 45:751–62
Cohen S, Hurd E, Cush J et al (2002) Treatment of rheumatoid arthritis with Ankinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate. Arthritis Rheum 46:614–24
Hawkins PN, Lachmann HJ, Aganna E et al (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to Anakinra. Arthritis Rheum 50:607–12
Lovell DJ, Bowyer SL, Solinger AM (2005) Interleukin-1 blockade by Anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease. Arthritis Rheum 52:1283–286
Kauffman CL, Aria N, Toichi E et al (2004) A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. J Invest Dermatol 123:1037–044
Mannon PJ, Fuss IJ, Mayer L et al (2004) Anti-interleukin-12 antibody for active Crohn’s disease. N Engl J Med 351:2069–079
Di Virgilio F, Chiozzi P, Ferrari D et al (2001) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587–00
Di Virgilio F, Baricordi OR, Romagnoli R et al (2005) Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapy. Curr Drug Targets: Cardiovasc Hematol Disord 5:85–9
Dubyak GR, Cliffor EE, Humphreys BD et al (1996) Expression of multiple ATP receptor subtypes during the differentiation and inflammatory activation of myeloid leukocytes. Drug Dev Res 39:269–78
Jin J, Dasari VR, Sistare FD et al (1998) Distribution of P2Y2 receptor subtypes on haematopoietic cells. Br J Pharmacol 123:789–94
Gudipaty L, Humphreys BD, Buell G et al (2001) Regulation of P2X7 nucleotide receptor function in human monocytes by extracellular ions and receptor density. Am J Physiol Cell Physiol 280:C943–C953
Wiley JS, Dubyak GR (1989) Extracellular adenosine triphosphate increases cation permeability of chronic lymphocytic leukemic lymphocytes. Blood 73:1316–323
Gu B, Bendall LJ, Wiley JS (1998) Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 92:946–51
Gu BJ, Zhnag WY, Bendall LJ et al (2000) Expression of P2X7 purinoceptors on human lymphocytes and monocytes: evidence for non-functional P2X7 receptors. Am J Physiol Cell Physiol 279:C1189–C1197
Sluyter R, Barden JA, Wiley JS (2001) Detection of P2X purinergic receptors on human B lymphocytes. Cell Tissue Res 304:231–36
Adinolfi E, Melchiorri L, Falzoni S et al (2002) P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 99:706–08
Suh B-C, Kim J-S, Namgung U et al (2001) P2X7 nucleotide receptor mediation of membrane pore formation and superoxide generation in human promyelocytes and neutrophils. J Immunol 166:6754–763
Bulanova E, Budagian V, Orinska Z et al (2005) Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol 174:3880–890
Idzko M, Panther E, Bremer HC et al (2003) Stimulation of P2 purinergic receptors induces the release of eosinophil cationic protein and interleukin-8 from human eosinophils. Br J Pharmacol 138:1244–250
Chen Y-W, Donnelly-Roberts DL, Namovic MT et al (2005) Pharmacological characterization of P2X7 receptors in rat peritoneal macrophages. Inflamm Res 54:119–26
Solle M, Labasi J, Perregaux DG et al (2001) Altered cytokine production in mice lacking P2X7 receptors. J Biol Chem 276:125–32
Sung S-SJ, Young JD-E, Origlio AM et al (1985) Extracellular ATP perturbs transmembrane ion fluxes, elevates cytosolic [Ca2+], and inhibits phagocytosis in mouse macrophages. J Biol Chem 260:13442–3449
Steinberg TH, Newman AS, Swanson JA et al (1987) ATP4- permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J Biol Chem 262:8884–888
Surprenant A, Rassendren F, Kawashima E et al (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272:735–38
Chessell IP, Simon J, Hibell AD et al (1998) Cloning and functional characterization of the mouse P2X7 receptor. FEBS Lett 439:26–0
Coutinho-Silva R, Ojcius DM, Gorecki DC et al (2004) Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages. Biochem Pharmacol 69:641–55
Ferrari D, Chiozzi P, Falzoni S et al (1997) ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36:1295–301
Collo G, Neidhart S, Kawashima E et al (1997) Tissue distribution of the P2X7 receptor. Neuropharmacology 36:1277–283
Hickman SE, El Khoury J, Greenberg S et al (1994) P2Z adenosine triphosphate receptor activity in cultured human monocyte-derived macrophages. Blood 84:2452–456
Falzoni S, Munerati M, Ferrari D et al (1995) The purinergic P2Z receptor of human macrophage cells. Clin Invest 95:1207–216
Humphreys BD, Dubyak GR (1996) Induction of the P2Z/P2X7 nucleotide receptor and associated phospholipase activity by lipopolysaccharide and IFN-γ in the human THP-1 monocytic cell line. J Immunol 157:5627–637
Berchtold S, Ogilvie ALJ, Bogdan C et al (1999) Human monocyte derived dendritic cells express functional P2X and P2Y receptors as well as ecto-nucleotidases. FEBS Lett 458:424–28
Ferrari D, La Sala A, Chiozzi P et al (2000) The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. FASEB J 14:2466–476
Zhang FL, Luo L, Gustafson E et al (2002) P2Y13: identification and characterization of a novel Gαi-coupled ADP receptor from human and mouse. J Pharmacol Exp Ther 301:705–13
Mutini C, Falzoni S, Ferrari D et al (1999) Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. J Immunol 163:1958–965
Ralevic V, Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413–92
Luster AD (1998) Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338:436–55
Mukaida N (2003) Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol 284:L566–L577
Warny M, Aboudola S, Robson SC et al (2001) P2Y6 nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J Biol Chem 276:26051–6056
Cox MA, Gomes B, Plamer K et al (2005) The pyrimidinergic P2Y6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem Biophys Res Commun 330:467–73
Dubyak GR, el-Moatassim C (1993) Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 265:C577–C606
Boeynaems J-M, Communi D, Gonzalez NS et al (2005) Overview of the P2 receptors. Semin Thromb Hemost 31:139–49
Korcok J, Raimundo LN, Du X et al (2005) P2Y6 nucleotide receptors activate NF-κB and increase survival of osteoclasts. J Biol Chem 280:16909–6915
Baeuerle PA, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141–79
Dolmetsch RE, Xu K, Lewis RS (1998) Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933–36
Somers GR, Hammett FMA, Trute L et al (1998) Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease. Lab Invest 78:1375–383
Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133–46
Trinchieri G, Pflanz S, Kastelein RA (2003) The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641–44
Langrish CL, McKenzie BS, Wilson NJ et al (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202:96–05
Watford WT, Hissong BD, Bream JH et al (2004) Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol Rev 202:139–56
Aggarwal S, Ghilardi N, Xie M-H et al (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–914
Langrish CL, Chen Y, Blumenschein WM et al (2005) IL-23 drives pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–40
Moss RB, Moll T, El-Kalay M et al (2005) Th1/Th2 cells in inflammatory disease states: therapeutic implications. Expet Opin Biol Ther 4:1887–896
Schnurr M, Then F, Galambos P et al (2000) Extracellular ATP and TNF-α synergise in the activation and maturation of human dendritic cells. J Immunol 165:4704–709
la Salla A, Sebastiani S, Ferrari D et al (2002) Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. Blood 99:1715-1722
la Sala A, Ferrari D, Corinti S et al (2001) Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J Immunol 166:1611-1617
Wilkin F, Duhant X, Bruyns C et al (2001) The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 166:7172–177
Wilkin F, Stordeur P, Goldman M et al (2002) Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol 32:2409–417
D’Andrea A, Rengaraju M, Valiante NM et al (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387–398
Schnurr M, Toy T, Shin A et al (2005) Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 105:1582–589
Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological properties similar as well as distinct from IL-12. Immunity 13:715–25
Marteau F, Communi D, Boeynaems J-M et al (2004) Involvement of multiple P2Y receptors and signaling pathways in the action of adenine nucleotide diphosphates on human monocyte-derived dendritic cells. J Leukoc Biol 76:796–03
Narumiya S, Sugimoto Y, Ushikubi F (1999) Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193–225
Nataraj C, Thomas DW, Tilley SL et al (2001) Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse. J Clin Invest 108:1229–235
Braun MC, Kelsall BL (2001) Regulation of interleukin-12 production by G-protein-coupled receptors. Microbes Infect 3:99–07
Granstein RD, Ding W, Huang J et al (2005) Augmentation of cutaneous immune responses by ATPγS: purinergic agonists define a novel class of immunologic adjuvants. J Immunol 174:7725–731
Mizumoto N, Kumamoto T, Robson SC et al (2002) CD39 is the dominant Langehans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8:358–65
Jarvis MF, Burgard EC, McGaraughty S et al (2002) A-317491, a potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc Nat Acad Sci 99:17179–7184
Gargett CE, Cornish JE, Wiley JS (1997) ATP, a partial agonist for the P2Z receptor of human lymphocytes. Br J Pharmacol 122:911–17
Bianchi BR, Lynch KJ, Touma E et al (1999) Pharmacological characterization of recombinant human and rat P2X receptor subtypes. Eur J Pharmacol 376:127–38
Murgia M, Hanau S, Pizzo P et al (1993) Oxidized ATP; an irreversible inhibitor of the macrophage purinergic P2X receptor. J Biol Chem 268:8199–203
Beigi RD, Kertesy SB, Aquilina G et al (2003) Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor-independent mechanisms. Br J Pharmacol 140:507–19
Hide I, Tanaka M, Inoue A et al (2000) Extracellular ATP triggers tumor necrosis factor-α release from rat microglia. J Neurochem 75:965–72
Tonetti M, Sturla L, Giovine M et al (1995) Extracellular ATP enhances mRNA levels of nitric oxide synthase and TNFα in lipopolysaccharide-treated RAW 264.7 murine macrophages. Biochem Biophys Res Commun 214:125–30
Hasko G, Kuhel DG, Salzman AL et al (2000) ATP suppression of interleukin-12 and tumour necrosis factor-α release from macrophages. Br J Pharmacol 129:909–14
Kucher BM, Neary JT (2005) Bi-functional effects of ATP/P2 receptor activation on tumor necrosis factor-alpha release in lipopolysaccharide-stimulated astrocytes. J Neurochem 92:525–35
Dinarello CA (1998) Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16:457–99
Cerretti DP, Lozlosky CJ, Mosley B et al (1992) Molecular cloning of the interleukin-1β converting enzyme. Science 256:97–00
Thornberry NA, Bull HG, Calaycay JR et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356:768–74
Kuida K, Lippke JA, Ku G et al (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1β converting enzyme. Science 267:2000–002
Ayala JM, Yamin TT, Egger LA et al (1994) IL-1β-converting enzyme is present in monocytic cells as an inactive 45 kDa precursor. J Immunol 153:2592–599
Hogquist KA, Unanue ER, Chaplin DD (1991) Release of IL-1 from mononuclear phagocytes. J Immunol 147:2181–186
Bhakdi S, Muhly M, Korom S et al (1990) Effects of Escherichia coli hemolysin on human monocytes. J Clin Invest 85:1746-1753
Walev I, Weller U, Strauch S et al (1996) Selective killing of human monocytes and cytokine release provoked by sphingomyelinase (beta-toxin) of Staphylococcus aureus. Infect Immun 64:2974–979
Verhoef PA, Kertesy SB, Estacion M et al (2004) Maitotoxin induces biphasic interleukin-1β secretion and membrane blebbing in murine macrophages. Mol Pharmacol 66:909–20
Cordoba-Rodriguez R, Fang H, Lankford CSR et al (2004) Anthrax lethal toxin rapidly activates caspase-1/ICE and induces extracellular release of interleukin (IL)-1β and IL-18. J Biol Chem 279:20563–0566
Kelk P, Claesson R, Hanstrom L et al (2005) Abundant secretion of bioactive interleukin-1β by human monocytes induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 73:453–58
Perregaux D, Bhavsar K, Contillo L et al (2002) Antimicrobial peptides initiate IL-1β posttranslational processing: a novel role beyond innate immunity. J Immunol 168:3024–032
Elssner A, Duncan M, Gavrilin M et al (2004) A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release. J Immunol 172:4987–994
Perregaux D, Barberia J, Lanzetti AJ et al (1992) IL-1β maturation: evidence that mature cytokine formation can be induced specifically by nigericin. J Immunol 149:1294–303
Walev I, Reske K, Palmer M et al (1995) Potassium-inhibited processing of IL-1β in human monocytes. EMBO J 14:1607–614
Cheneval D, Ramage P, Kastelic T et al (1998) Increased mature interleukin-1β (IL-1β) secretion from THP- cells induced by nigericin is a result of activation of p45 IL-1β-converting enzyme processing. J Biol Chem 273:17846–7851
Hogquist KA, Nett MA, Unanue ER et al (1991) Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci 88:8485–489
Griffiths RJ, Stam EJ, Downs J et al (1995) ATP induces the release of IL-1 from LPS primed cells in vivo. J Immunol 154:2821–828
Perregaux D, Gabel CA (1994) Interleukin1-β maturation and release in response to ATP and nigericin. J Biol Chem 269:15195–5203
Ferrari D, Chiozzi P, Falzoni S et al (1997) Extracellular ATP triggers IL-1β release by activating the purinerigic P2Z receptor on human macrophages. J Immunol 159:1451–458
Grahames CBA, Michel AD, Chessell IP et al (1999) Pharmacological characterization of ATP- and LPS-induced IL-1β release in human monocytes. Br J Pharmacol 127:1915–921
Ferrari D, Villalba M, Chiozzi P et al (1996) Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J Immunol 156:1531–539
Ferrari D, Chiozzi P, Falzoni S et al (1997) Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J Exp Med 185:1–
Rampe D, Wang L, Ringheim GE (2004) P2X7 receptor modulation of β-amyloid- and LPS-induced cytokine secretion from human macrophages and microglia. J Neuroimmunol 147:56–1
Gargett CE, Wiley JS (1997) The isoquinoline derivative KN-62: a potent antagonist of the P2Z-receptor of human lymphoctytes. Br J Pharmacol 122:911–17
Humphreys BD, Virginio C, Surprenant A et al (1998) Isoquinolines as antagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat receptor homologues. Mol Pharmacol 54:22–2
Buell G, Chessell IP, Michel AD et al (1998) Blockade of human P2X7 receptor function with a monoclonal antibody. Blood 92:3521–528
Bradford MD, Soltoff SP (2002) P2X7 receptors activate protein kinase (MAPK) downstream of protein kinase C. Biochem J 366:745–55
Amstrup J, Novak I (2003) P2X7 receptor activates extracellular signal-regulated kinases ERK1 and ERK2 independently of Ca2+ influx. Biochem J 374:51–1
Auger R, Motta I, Benihoud K et al (2005) A role for mitogen-activated protein kinaseErk1/2 activation and non-selective pore formation in P2X7 receptor-mediated thymocyte death. J Biol Chem 280:28142–8151
Humphreys BD, Rice J, Kertesy SB et al (2000) Stress-activated protein kinase/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275:26792–6798
Verhoef PA, Estacion M, Schilling W et al (2003) P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1β release. J Immunol 170:5728–738
Pfeiffer ZA, Aga M, Prabhu U et al (2004) The neucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J Leukoc Biol 75:1173–182
Budagian V, Bulanova E, Brovko L et al (2003) Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-κB. J Biol Chem 278:1549–560
Adinolfi E, Kim M, Young MT et al (2003) Tyrosine phosphorylation of HSP90 within the P2X7 receptor complex negatively regulates P2X7 receptors. J Biol Chem 278:37344–7351
Feng Y-H, Wang L, Wang Q et al (2005) ATP stimulates GRK-3 phosphorylation and B-arrestin-2-dependent internalization of P2X7 receptor. Am J Physiol 288:C1342–C1356
Kim M, Jian LH, Wilson HL et al (2001) Proteomic and functional evidence for a P2X7 receptor signaling complex. EMBO J 20:6347–358
Ferrari D, Wesselborg S, Baurer MKA et al (1997) Extracellular ATP activates transcription factor NF-kB through the P2Z purinoreceptor by selectively targeting NF-κB p65 (RelA). J Cell Biol 139:1635–643
Ferrari D, Stroh C, Schulze-Osthoff K (1999) P2X7/P2Z purinoreceptor-mediated activation of transcription factor NFAT in microglial cells. J Biol Chem 274:13205–3210
Parvathenani LK, Tertyshnikova S, Creco CR et al (2003) P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer’s disease. J Biol Chem 278:13309–3317
Garcia-Marcos M, Fontanils U, Aguirre A et al (2005) Role of sodium in mitochondrial membrane depolarization induced by P2X7 receptor activation in submandibular glands. FEBS Lett 579:5407–413
Humphreys BD, Dubyak GR (1996) Induction of the P2X/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFNγ in the human THP-1 monocytic cell line. J Immunol 157:5627–637
Mehta VB, Hart J, Wewers MD (2001) ATP-stimulated release of interleukin (IL)-1β and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem 276:3820–826
Kahlenberg JM, Dubyak GR (2003) Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release. Am J Physiol 286:C1100–C1108
North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013–067
Brough D, Le Feuvre RA, Wheeler RD et al (2003) Ca2+ stores and Ca2+ entry differentially contribute to the release of IL-1β and IL-1α from murine macrophages. J Immunol 170:3029–036
Gudipaty L, Munetz J, Verhoef PA et al (2003) Essential role for Ca2+ in regulation of IL-1β secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK293 cells. Am J Phyisol 285:C286–C299
Perregaux DG, Gabel CA (1998) Human monocyte stimulus-coupled IL-1β posttranslational processing: modulation via monovalent cations. Am J Physiol 275:C1538–C1547
Laliberte RE, Eggler J, Gabel CA (1999) ATP treatment of human monocytes promotes caspase-1 maturation and externalization. J Biol Chem 274:36944–6951
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-1β. Mol Cell 10:417–26
Tschopp J, Martinon F, Burns K (2003) NALPS: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4:95–04
Dowds TA, Masumoto J, Zhu L et al (2004) Cryopyrin-induced interleukin 1β secretion in monocytic cells. J Biol Chem 279:21924–1928
Bruey JM, Rruey-Sedano N, Newman R et al (2004) PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-κB and caspase-1 activation in macrophages. J Biol Chem 279:51897–1907
Martinon F, Tschopp J (2004) Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117:561–74
Mariathasan S, Newton K, Monack DM et al (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430:213–18
MacKenzie A, Wilson HL, Kiss-Toth E et al (2001) Rapid secretion of interleukin-1β by microvesicle shedding. Immunity 8:825–35
Faria RX, DeFarias FP, Alves LA (2005) Are second messengers crucial for opening the pore associated with P2X7 receptor? Am J Physiol 288:C260–C271
Mackenzie AB, Young MT, Adinolfi E et al (2005) Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors. J Biol Chem 280:33968–3976
Perregaux DG, Gabel CA (1998) Post-translational processing of murine IL-1: evidence that ATP-induced release of IL-1α and IL-1β occurs via a similar mechanism. J Immunol 160:2469–477
Hamon Y, Luciani M-F, Becq F et al (1997) Interleukin-1β secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90:2911–915
Bianco F, Pravettoni E, Colombo A et al (2005) Astrocyte-derived ATP induces vesicle shedding and IL-1β release from microglia. J Immunol 174:7268–277
Andrei C, Dazzi C, Lotti L et al (1999) The secretory route of the leaderless protein interleukin 1β involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 10:1463–475
Andrei C, Margiocco P, Poggi A et al (2005) Phospholipases C and A2 control lysosome-mediated IL-1β secretion: implications for inflammatory processes. Proc Natl Acad Sci 101:9745–750
Wiley JS, Dao-Ung LP, Gu BJ et al (2002) A loss-of function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukemia: a molecular study. Lancet 359:1114–119
Li CM, Campbell SJ, Kumararatne DS et al (2002) Response heterogeneity of human macrophages to ATP is associated with P2X7 receptor expression but not to polymorphisms in the P2RX7 promoter. FEBS Lett 531:127–31
Zhang LY, Ibbotson RE, Orchard JA et al (2003) P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia 17:2097–100
Le Stunff H, Auger R, Kanellopoulos J et al (2004) The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes. J Biol Chem 279:16918–6926
Skarratt KK, Fuller SJ, Sluyter R et al (2005) A 5–intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1–% of the Caucasian population. FEBS Lett 579:2675–678
Cabrini G, Falzoni S, Forchap SL et al (2005) A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol 175:82–9
Gu BJM, Sluyter R, Skarratt KK et al (2004) An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. J Biol Chem 279:31287–1295
Sluyter R, Shemon AN, Wiley JS (2004) Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1β release from human monocytes. J Immunol 172:3399–405
Sluyter R, Dalitz JG, Wiley JS (2004) P2X7 receptor polymorphism impairs extracellular adenosine 5–triphosphate-induced interleukin-18 release from human monocytes. Genes Immun 5:588–91
Chessell IP, Hatcher JP, Bountra C et al (2005) Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114:386–96
Joosten LA, Helsen MM, Saxne T et al (1999) IL-1α/β blockade prevents cartilage and bond destruction in murine type II collagen-induced arthritis, whereas TNFα blockade only ameliorates joint inflammation. J Immunol 163:5049–055
Williams RO, Marinova-Mutafchieva L, Feldmann M et al (2000) Evaluation of TNFα and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNFα/anti-CD4 therapy. J Immunol 165:7240–245
Kagari T, Doi H, Shimozato T (2002) The importance of IL-1β and TNFα, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 169:1459–466
Baxter A, Bent J, Bowers K et al (2003) Hit-to-lead studies: the discovery of potent adamantine amide P2X7 receptor antagonists. Bioorg Med Chem Lett 13:4047–050
Merriman GH, Ma L, Shum P et al (2005) Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonists. Bioorg Med Chem Lett 15:435–38
Romagnoli R, Baraldi PG, Di Virgilio F (2005) Recent progress in the discovery of antagonists acting at P2X7 receptor. Expert Opin Ther Pat 15:271–87
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4